Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, physician nephrology, ambulant treatment, and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an)

The latest update is out from Foremost Lithium Resource & Technology Ltd ( ($TSE:FAT) ). Foremost Clean Energy Ltd. has announced promising assay r...

Foremost Clean Energy Reports High-Grade Gold Success at Jean Lake

An update from Fresenius Medical Care ( ($FMS) ) is now available. On November 17, 2025, Fresenius Medical Care successfully placed a €500 million ...

Fresenius Medical Care Issues €500 Million Bond to Strengthen Financial Position

Foremost Lithium Resource & Technology Ltd ( ($TSE:FAT) ) just unveiled an announcement. Foremost Clean Energy Ltd. has successfully completed a 2,...

Foremost Clean Energy Completes Successful Drill Program at Murphy Lake South

Morgan Stanley analyst Robert Davies maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA today and set a price target of €39.00. Davie...

Morgan Stanley Sticks to Their Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

In a report released today, Richard Felton from Goldman Sachs maintained a Buy rating on Fresenius Medical Care AG & Co. KGaA, with a price target ...

Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Buy from Goldman Sachs

In a report released today, David S Macdonald from Truist Financial maintained a Hold rating on Fresenius Medical Care. The company’s shares closed...

Truist Financial Reaffirms Their Hold Rating on Fresenius Medical Care (FMS)

UBS analyst Graham Doyle maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA today and set a price target of €38.00. The company’s sha...

Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Sell from UBS

In a report released today, James Vane from Jefferies maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA, with a price target of €36....

Jefferies Keeps Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

J.P. Morgan analyst David Adlington maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA today and set a price target of €41.50. The co...

Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Sell from J.P. Morgan

Foremost Lithium Resource & Technology Ltd ( ($TSE:FAT) ) has provided an update. Foremost Clean Energy Ltd. announced a significant increase in ur...

Market Cap	$13.47B	P/E Ratio	10.64
52W High	$30.46	52W Low	$21.83
Div Yield	78.7%	Payout Ratio	N/A
EPS Growth 3Y	0.0%	52W Position	18.3%
Overall Score	58	Value Score	80
Quality Score	--	Technical Score	36

EPS Current Est	$2.2	EPS Next Est	$2.44
EPS Growth Est	+10.9%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	FMS	$23.41	+3.63%	688.70K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	FMS	$23.41	+3.6%	688.70K
3
4
5
6

FMS

FMS

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an) Data in Excel

Get Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an) Data in Excel